Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Typing System for Early Screening and Diagnosis of Lung Cancer Combined With Liquid Biopsy Technology

NCT05432128 is registered in ClinicalTrials.gov with Singlera Genomics Inc. as lead sponsor.

NCT NCT05432128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05432128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Typing System for Early Screening and Diagnosis of Lung Cancer Combined With Liquid Biopsy Technology
Lead sponsor
Singlera Genomics Inc.
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 31, 2025
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer